E
Addex Therapeutics Ltd ADXN
$6.07 $0.132.19% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -16.62% -- -- -19.33% 22.38%
Total Depreciation and Amortization 3.85% -- -- -91.14% -56.22%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 18.10% -- -- 20.67% -25.04%
Change in Net Operating Assets 8.70% -- -- -103.89% 227.77%
Cash from Operations -16.32% -- -- -2,385.07% 94.18%
Capital Expenditure -- -- -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -105.73% -- -- -- -241.51%
Cash from Investing -105.73% -- -- -- -166.18%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -5.56% -- -- 0.00% 18.18%
Issuance of Common Stock -76.79% -- -- -94.64% --
Repurchase of Common Stock -140.74% -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -66.67% -- -- 1,876.79% -429.41%
Cash from Financing -79.02% -- -- 5,550.00% -233.33%
Foreign Exchange rate Adjustments 9.52% -- -- -145.05% 198.71%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -382.91% -- -- -6,656.47% 98.32%